AdvanSix Inc (NASDAQ:ASIX) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a report issued on Tuesday. The firm currently has a $39.00 price target on the stock. Zacks Investment Research‘s target price points to a potential upside of 13.34% from the stock’s previous close.

According to Zacks, “AdvanSix Inc. is a producer and supplier of Nylon 6 materials. The company’s polymer resin sold under the Aegis(R) brand to produce engineered plastics, fibers, filaments and films which in turn used in end products such as automotive and electronic components, carpets, sports apparel, fishing nets and food as well as industrial packaging. AdvanSix also produces caprolactam, the main feedstock for producing nylon; Caprannylon film(R); Sulf-N (R) ammonium sulfate fertilizers and chemical intermediates, including phenol, acetone, and Nadone (R) cyclohexanone. AdvanSix Inc. is based in Morris Plains, United States. “

Separately, Cowen and Company initiated coverage on AdvanSix in a report on Friday, June 23rd. They set an “outperform” rating and a $37.00 price target on the stock.

AdvanSix (ASIX) traded up 0.70% during mid-day trading on Tuesday, reaching $34.41. The company’s stock had a trading volume of 79,187 shares. The firm has a market cap of $1.05 billion and a PE ratio of 23.63. AdvanSix has a one year low of $12.00 and a one year high of $34.79. The stock’s 50 day moving average is $34.17 and its 200 day moving average is $28.74.

AdvanSix (NASDAQ:ASIX) last issued its quarterly earnings data on Thursday, August 10th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.17. AdvanSix had a return on equity of 40.03% and a net margin of 7.13%. The company had revenue of $361.44 million for the quarter. On average, analysts anticipate that AdvanSix will post $2.83 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/09/12/advansix-inc-asix-upgraded-at-zacks-investment-research.html.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. SG Americas Securities LLC purchased a new position in shares of AdvanSix during the second quarter worth about $100,000. Pacad Investment Ltd. grew its holdings in shares of AdvanSix by 16.7% during the second quarter. Pacad Investment Ltd. now owns 3,500 shares of the company’s stock worth $109,000 after buying an additional 500 shares during the last quarter. Pinebridge Investments L.P. grew its holdings in shares of AdvanSix by 13.6% during the second quarter. Pinebridge Investments L.P. now owns 4,509 shares of the company’s stock worth $141,000 after buying an additional 539 shares during the last quarter. Quantbot Technologies LP grew its holdings in shares of AdvanSix by 772.8% during the second quarter. Quantbot Technologies LP now owns 4,783 shares of the company’s stock worth $149,000 after buying an additional 4,235 shares during the last quarter. Finally, Private Advisor Group LLC purchased a new position in shares of AdvanSix during the second quarter worth about $227,000.

About AdvanSix

AdvanSix Inc is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia.

Receive News & Stock Ratings for AdvanSix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix Inc and related stocks with our FREE daily email newsletter.